BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20554995)

  • 1. Pharmacological ascorbic acid suppresses syngeneic tumor growth and metastases in hormone-refractory prostate cancer.
    Pollard HB; Levine MA; Eidelman O; Pollard M
    In Vivo; 2010; 24(3):249-55. PubMed ID: 20554995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.
    Neubauer BL; Best KL; Counts DF; Goode RL; Hoover DM; Jones CD; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
    Prostate; 1995 Oct; 27(4):220-9. PubMed ID: 7479389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic spread of the PAIII prostatic adenocarcinoma after implantation in the tail of the rat.
    Neubauer BL; Bemis KG; Best KL; Goode RL; Merriman RL; Smith GF; Tanzer LR; Hoover DM
    Prostate; 1986; 8(3):265-76. PubMed ID: 3703746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PAIII rat prostatic adenocarcinoma growth and metastasis by a new diarylsulfonylurea antitumor agent, LY181984.
    Neubauer BL; Merriman RL; Best KL; Goode RL; Sarosdy MF; Tanzer LR; Howbert JJ
    J Urol; 1992 Feb; 147(2):500-4. PubMed ID: 1732631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative antitumor effects of hormonal ablation, estrogen agonist, estrogen cytotoxic derivative, and antiestrogen in the PAIII rat prostatic adenocarcinoma.
    Neubauer BL; Best KL; Goode RL; Heiman ML; Hoover DM; Robertson DW; Sarosdy MF; Shaar CJ; Tanzer LR; Merriman RL
    Cancer Res; 1992 Sep; 52(17):4663-71. PubMed ID: 1511432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
    Hodde JP; Suckow MA; Wolter WR; Hiles MC
    J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylseleninic acid downregulates hypoxia-inducible factor-1α in invasive prostate cancer.
    Sinha I; Null K; Wolter W; Suckow MA; King T; Pinto JT; Sinha R
    Int J Cancer; 2012 Mar; 130(6):1430-9. PubMed ID: 21500193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAIII prostate tumors express prostate specific antigen (PSA) in Lobund-Wistar rats.
    Suckow MA; Wheeler J; Yan M
    Can J Vet Res; 2009 Jan; 73(1):39-41. PubMed ID: 19337394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.
    Neubauer BL; Bemis KG; Best KL; Goode RL; Hoover DM; Smith GF; Tanzer LR; Merriman RL
    J Urol; 1986 Jan; 135(1):163-6. PubMed ID: 3941458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL; McNulty AM; Chedid M; Chen K; Goode RL; Johnson MA; Jones CD; Krishnan V; Lynch R; Osborne HE; Graff JR
    Cancer Res; 2003 Sep; 63(18):6056-62. PubMed ID: 14522935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor properties of selenocoxib-1 against rat prostate adenocarcinoma cells.
    Desai D; Sinha I; Null K; Wolter W; Suckow MA; King T; Amin S; Sinha R
    Int J Cancer; 2010 Jul; 127(1):230-8. PubMed ID: 19918950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.
    Momma T; Hamblin MR; Wu HC; Hasan T
    Cancer Res; 1998 Dec; 58(23):5425-31. PubMed ID: 9850075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats.
    Pollard M
    Cancer Lett; 1996 Mar; 101(1):21-4. PubMed ID: 8625277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.
    Hautmann S; Huland E; Wullbrand A; Friedrich M; Huland H
    Anticancer Res; 2000; 20(6B):4495-8. PubMed ID: 11205294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.
    Tuomela JM; Valta MP; Väänänen K; Härkönen PL
    BMC Cancer; 2008 Mar; 8():81. PubMed ID: 18371232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
    Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
    Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of metastasis of prostate adenocarcinoma cells by immune-suppressive cyclosporine A.
    Pollard M
    Cancer Lett; 1997 Jan; 111(1-2):221-4. PubMed ID: 9022150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantable metastasizing prostate adenocarcinomas in rats.
    Pollard M; Luckert PH
    J Natl Cancer Inst; 1975 Mar; 54(3):643-9. PubMed ID: 1123852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.